论文部分内容阅读
Zhongshan Ophthalmic Center (ZOC) is the top institution in China and one of the 20 tops worldwide for clinical treatment and basic research of ocular diseases. Positions are available to investigate ocular pharmacology. Focus is on therapeutic approach to retinal/macular degeneration, infection/inflammation, myopia and glaucoma. Two years commitment will be carried out at ZOC in Guangzhou and at Harvard in Boston. Successful candidates will be selfmotivated with strong experience in molecular pharmacology. Experience in ophthalmology is helpful, but not essential. Send CV, a statement of research accomplishments, goals, and names of three references to: Prof Mark S Hu, MD, PhD, Zhongshan Ophthalmic Center, 54 S Xianlie Road, Guangzhou 510060, P.R. China. Fax: +86-20-87333271. E-mail markhu@ gzsums. edu. cn
Focus on on therapeutic approach to retinal/macular degeneration, infection/ Inflammation, myopia and glaucoma. Two years commitment will be carried out at ZOC in Guangzhou and at Harvard in Boston. Successful candidates will be selfmotivated with strong experience in molecular pharmacology. Experience in ophthalmology is helpful, but not essential. Send CV, a statement Of research accomplishments, goals, and names of three references to: Prof Mark S Hu, MD, PhD, Zhongshan Ophthalmic Center, 54 S Xianlie Road, Guangzhou 510060, PR China. Fax: +86-20-87333271. E-mail markhu @ gzsums. edu. cn